{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:14:58Z","timestamp":1774440898749,"version":"3.50.1"},"reference-count":33,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1536\/ihj.16-020","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T22:12:09Z","timestamp":1484604729000},"page":"100-106","source":"Crossref","is-referenced-by-count":26,"title":["microRNA-10a Targets T-box 5 to Inhibit the Development of Cardiac Hypertrophy"],"prefix":"10.1536","volume":"58","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[{"name":"Fifth Department of Cardiology, Zhengzhou Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanqun","family":"Zhai","sequence":"additional","affiliation":[{"name":"Fifth Department of Cardiology, Zhengzhou Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangfei","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Jing","sequence":"additional","affiliation":[{"name":"Fifth Department of Cardiology, Zhengzhou Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wang K, Lin ZQ, Long B, Li JH, Zhou J, Li PF. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. J Biol Chem 2012; 287: 589-99.","DOI":"10.1074\/jbc.M111.266940"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy maintenance of cardiac function and causative roles in heart failure. Circ Res 2014; 114: 565-71. (Review)","DOI":"10.1161\/CIRCRESAHA.114.300507"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Imamura T, Kinugawa K, Nitta D, Kinoshita O, Nawata K, Ono M. Everolimus attenuates myocardial hypertrophy and improves diastolic function in heart transplant recipients. Int Heart J 2016; 57: 204-10.","DOI":"10.1536\/ihj.15-320"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Imamura T, Amiya E, Nitta D, Kinugawa K. Everolimus-incorporated therapy reduces myocardial hypertrophy in recipients of heart transplantation. Int Heart J 2016; 57: 389-90.","DOI":"10.1536\/ihj.16-040"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97. (Review)","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Gladka MM, da Costa Martins PA, De Windt LJ. Small changes can make a big difference - microRNA regulation of cardiac hypertrophy. J Mol Cell Cardiol 2012; 52: 74-82. (Review)","DOI":"10.1016\/j.yjmcc.2011.09.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Feng HJ, Ouyang W, Liu JH, <i>et al<\/i>. Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy. Braz J Med Biol Res 2014; 47: 361-8.","DOI":"10.1590\/1414-431X20142937"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Ooi JY, Bernardo BC, McMullen JR. The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med Chem 2014; 6: 205-22. (Review)","DOI":"10.4155\/fmc.13.196"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Seok HY, Chen J, Kataoka M, <i>et al<\/i>. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy. Circ Res 2014; 114: 1585-95.","DOI":"10.1161\/CIRCRESAHA.114.303784"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Li C, Li X, Gao X, <i>et al<\/i>. MicroRNA-328 as a regulator of cardiac hypertrophy. Int J Cardiol 2014; 173: 268-76.","DOI":"10.1016\/j.ijcard.2014.02.035"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Ohuchida K, Mizumoto K, Lin C, <i>et al<\/i>. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012; 19: 2394-402.","DOI":"10.1245\/s10434-012-2252-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Chang CH, Fan TC, Yu JC, <i>et al<\/i>. The prognostic significance of RUNX2 and miR-10a\/10b and their inter-relationship in breast cancer. J Transl Med 2014; 12: 257.","DOI":"10.1186\/s12967-014-0257-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Liang D, Zhen L, Yuan T, <i>et al<\/i>. miR-10a regulates proliferation of human cardiomyocyte progenitor cells by targeting GATA6. PLoS One 2014; 9: e103097.","DOI":"10.1371\/journal.pone.0103097"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Yamakawa H, Ieda M. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming. Int Heart J 2015; 56: 1-5. (Review)","DOI":"10.1536\/ihj.14-344"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Matsuura K, Shimizu T, Okano T. Toward the development of bioengineered human three-dimensional vascularized cardiac tissue using cell sheet technology. Int Heart J 2014; 55: 1-7. (Review)","DOI":"10.1536\/ihj.13-337"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Han JJ, Hao J, Kim CH, Hong JS, Ahn HY, Lee YS. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci 2009; 71: 737-43.","DOI":"10.1292\/jvms.71.737"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Woodcock EA, Wang BH, Arthur JF, <i>et al<\/i>. Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor. J Biol Chem 2002; 277: 22734-42.","DOI":"10.1074\/jbc.M110405200"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Custodis F, Eberl M, Kilter H, B\u00f6hm M, Laufs U. Association of RhoGDI\u03b1with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 2006; 71: 342-51.","DOI":"10.1016\/j.cardiores.2006.04.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. ELife 2015; 4: e05005.","DOI":"10.7554\/eLife.05005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.","DOI":"10.1006\/meth.2001.1262"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. van de Vrie M, Heymans S, Schroen B. MicroRNA involvement in immune activation during heart failure. Cardiovasc Drugs Ther 2011; 25: 161-70. (Review)","DOI":"10.1007\/s10557-011-6291-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Wang J, Yang X. The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci 2012; 69: 3561-70. (Review)","DOI":"10.1007\/s00018-012-1126-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Basson M. Cardiac hypertrophy: A miRNA star in the heart. Nat Med 2014; 20: 595.","DOI":"10.1038\/nm.3604"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Wang K, Long B, Zhou J, Li PF. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem 2010; 285: 11903-12.","DOI":"10.1074\/jbc.M109.098004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98\/let-7. Circ Res 2011; 108: 305-13.","DOI":"10.1161\/CIRCRESAHA.110.228437"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Hassel D, Cheng P, White MP, <i>et al<\/i>. MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. Circ Res 2012; 111: 1421-33.","DOI":"10.1161\/CIRCRESAHA.112.279711"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Long MJ, Wu FX, Li P, <i>et al<\/i>. MiRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett 2012; 324: 186-96.","DOI":"10.1016\/j.canlet.2012.05.022"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Yu T, Liu L, Li J, <i>et al<\/i>. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN. Oncotarget 2015; 6: 30239-50.","DOI":"10.18632\/oncotarget.4972"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Yan Y, Wang Q, Yan XL, <i>et al<\/i>. miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8. FEBS Lett 2015; 589: 756-65.","DOI":"10.1016\/j.febslet.2015.02.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Plageman TF Jr, Yutzey KE. T-box genes and heart development: putting the \u201cT\u201d in heart. Dev Dyn 2005; 232: 11-20. (Review)","DOI":"10.1002\/dvdy.20201"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Horb ME, Thomsen GH. Tbx5 is essential for heart development. Development 1999; 126: 1739-51.","DOI":"10.1242\/dev.126.8.1739"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Goetz SC, Brown DD, Conlon FL. TBX5 is required for embryonic cardiac cell cycle progression. Development 2006; 133: 2575-84.","DOI":"10.1242\/dev.02420"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34. Smemo S, Campos LC, Moskowitz IP, Krieger JE, Pereira AC, Nobrega MA. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet 2012; 21: 3255-63.","DOI":"10.1093\/hmg\/dds165"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/1\/58_16-020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T21:28:32Z","timestamp":1658438912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/1\/58_16-020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-020","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}